Professor Solange Peters is one of the most influential global leaders in thoracic oncology. Full Professor and Chair of Medical Oncology and Thoracic Malignancies at Lausanne University Hospital (CHUV), she has built a career that seamlessly integrates clinical excellence, scientific innovation, and institutional leadership, ensuring that advances in cancer research meaningfully benefit patients.

Trained in Lausanne, where she earned both her MD and PhD, and further specialized in Switzerland and Italy, Prof. Peters has focused her work on lung and pleural cancers. She has developed a strong translational research program in collaboration with EPFL and the Ludwig Institute, with key areas of interest including biomarker discovery, multimodality strategies for locally advanced non–small cell lung cancer, and novel immunotherapy combinations across thoracic tumors.

She has authored numerous peer-reviewed publications and book chapters, has served as associate editor of Annals of Oncology, and sits on several editorial boards. She has led or co-led major clinical trials in thoracic oncology and plays a central role in international research networks, including as scientific coordinator and council member of the European Thoracic Oncology Platform.

Prof. Peters is also deeply committed to education and scientific leadership. As the youngest-ever President of ESMO (2020–2022) and former board member of IASLC, she has shaped global oncology policy and promoted equity, collaboration, and innovation in cancer care.

Her career embodies scientific rigor, visionary leadership, and a profound impact on the modern management of lung cancer.